EXTENSIVE STAGE SMALL CELL LUNG CARCINOMA
Clinical trials for EXTENSIVE STAGE SMALL CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVE STAGE SMALL CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for EXTENSIVE STAGE SMALL CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test Immune-Boosting drug with standard cancer treatments
Disease control CompletedThis early-stage trial tested whether adding the immunotherapy drug pembrolizumab to standard chemotherapy and radiation could be a better treatment for small cell lung cancer. The study involved 83 patients and focused on finding safe doses and understanding side effects. Resear…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 04, 2026 03:51 UTC
-
New drug combo tested as last hope for tough lung cancers
Disease control CompletedThis study tested a combination of two oral drugs, auranofin and sirolimus, for patients with advanced or returning lung cancer who had run out of standard treatment options. The main goals were to find the safest dose and see if the treatment could slow the cancer's growth. The …
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Brain radiation breakthrough: new technique aims to save memory while fighting cancer
Disease control CompletedThis study tested a new way to give preventive brain radiation to people with small cell lung cancer. Researchers wanted to see if carefully avoiding a key memory area of the brain during treatment could reduce side effects like memory loss, without making the radiation less effe…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC